6 Stocks That Have Come Too Far, Too Fast -- Barrons.com
Morgan Stanley Maintains NOV Inc(NOV.US) With Buy Rating, Maintains Target Price $25
BofA Securities Maintains NOV Inc(NOV.US) With Buy Rating, Announces Target Price $22
Piper Sandler Adjusts Price Target on NOV to $20 From $22, Maintains Neutral Rating
NOV Price Target Cut to $20.00/Share From $22.00 by Piper Sandler
NOV Is Maintained at Neutral by Piper Sandler
Piper Sandler Maintains NOV Inc(NOV.US) With Hold Rating, Cuts Target Price to $20
NOV Analyst Ratings
Express News | Nov Inc : BofA Global Research Cuts Price Objective to $22 From $24
Express News | Nov Inc : Piper Sandler Cuts Target Price to $20 From $22
Goldman Lists Its Top 25 Tactical Trades for Earnings Season
Express News | Nov Inc : TD Cowen Raises Target Price to $27 From $26
Is There An Opportunity With NOV Inc.'s (NYSE:NOV) 30% Undervaluation?
Insufficient Growth At NOV Inc. (NYSE:NOV) Hampers Share Price
NOV Announces Second Quarter 2024 Earnings Conference Call
NOV Inc To Go Ex-Dividend On June 14th, 2024 With 0.075 USD Dividend Per Share
Nov Inc. (NOV) Is a Top-Ranked Value Stock: Should You Buy?
NOV Inc. (NYSE:NOV) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
With EPS Growth And More, NOV (NYSE:NOV) Makes An Interesting Case
Express News | NYSE Order Imbalance 54381.0 Shares on Sell Side